Sika Valuation

Is 0Z4C undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0Z4C when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0Z4C (CHF228.6) is trading below our estimate of fair value (CHF269.98)

Significantly Below Fair Value: 0Z4C is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0Z4C?

Key metric: As 0Z4C is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0Z4C. This is calculated by dividing 0Z4C's market cap by their current earnings.
What is 0Z4C's PE Ratio?
PE Ratio29.4x
EarningsCHF 1.25b
Market CapCHF 36.67b

Price to Earnings Ratio vs Peers

How does 0Z4C's PE Ratio compare to its peers?

The above table shows the PE ratio for 0Z4C vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average25.3x
CRDA Croda International
30.3x15.1%UK£4.9b
JMAT Johnson Matthey
23.6x28.5%UK£2.5b
VCT Victrex
25.1x37.8%UK£769.6m
TET Treatt
22.1x15.3%UK£250.2m
0Z4C Sika
29.4x8.9%CHF 36.7b

Price-To-Earnings vs Peers: 0Z4C is expensive based on its Price-To-Earnings Ratio (29.4x) compared to the peer average (25.3x).


Price to Earnings Ratio vs Industry

How does 0Z4C's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
0Z4C 29.4xIndustry Avg. 17.1xNo. of Companies13PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0Z4C is expensive based on its Price-To-Earnings Ratio (29.4x) compared to the European Chemicals industry average (17.1x).


Price to Earnings Ratio vs Fair Ratio

What is 0Z4C's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0Z4C PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio29.4x
Fair PE Ratio19.5x

Price-To-Earnings vs Fair Ratio: 0Z4C is expensive based on its Price-To-Earnings Ratio (29.4x) compared to the estimated Fair Price-To-Earnings Ratio (19.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0Z4C forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 228.60
CHF 288.67
+26.3%
11.9%CHF 350.00CHF 220.00n/a21
Nov ’25CHF 242.69
CHF 291.76
+20.2%
13.0%CHF 370.00CHF 220.00n/a21
Oct ’25CHF 280.84
CHF 298.48
+6.3%
12.4%CHF 370.00CHF 230.00n/a21
Sep ’25CHF 272.00
CHF 296.00
+8.8%
12.8%CHF 380.00CHF 230.00n/a22
Aug ’25CHF 266.80
CHF 295.00
+10.6%
13.0%CHF 380.00CHF 230.00n/a22
Jul ’25CHF 255.38
CHF 295.68
+15.8%
12.8%CHF 380.00CHF 230.00n/a22
Jun ’25CHF 275.08
CHF 294.48
+7.1%
13.1%CHF 380.00CHF 230.00n/a21
May ’25CHF 263.30
CHF 293.76
+11.6%
13.2%CHF 380.00CHF 230.00n/a21
Apr ’25CHF 268.64
CHF 290.85
+8.3%
14.6%CHF 390.00CHF 224.00n/a20
Mar ’25CHF 257.53
CHF 288.19
+11.9%
14.5%CHF 390.00CHF 224.00n/a21
Feb ’25CHF 239.96
CHF 285.10
+18.8%
15.2%CHF 390.00CHF 230.00n/a21
Jan ’25CHF 273.60
CHF 283.19
+3.5%
16.1%CHF 380.00CHF 225.00n/a21
Dec ’24CHF 236.15
CHF 281.10
+19.0%
16.6%CHF 380.00CHF 223.00n/a21
Nov ’24CHF 215.20
CHF 282.43
+31.2%
16.2%CHF 380.00CHF 223.00CHF 242.6921
Oct ’24CHF 234.10
CHF 298.50
+27.5%
12.9%CHF 380.00CHF 230.00CHF 280.8421
Sep ’24CHF 247.34
CHF 300.09
+21.3%
13.0%CHF 380.00CHF 228.00CHF 272.0022
Aug ’24CHF 270.73
CHF 300.00
+10.8%
13.8%CHF 390.00CHF 228.00CHF 266.8021
Jul ’24CHF 248.50
CHF 304.05
+22.4%
14.8%CHF 390.00CHF 228.00CHF 255.3821
Jun ’24CHF 248.49
CHF 298.88
+20.3%
14.3%CHF 390.00CHF 228.00CHF 275.0821
May ’24CHF 244.27
CHF 295.43
+20.9%
14.3%CHF 390.00CHF 228.00CHF 263.3020
Apr ’24CHF 251.01
CHF 293.95
+17.1%
17.3%CHF 390.00CHF 162.95CHF 268.6422
Mar ’24CHF 262.20
CHF 292.13
+11.4%
17.6%CHF 390.00CHF 162.95CHF 257.5322
Feb ’24CHF 261.91
CHF 277.59
+6.0%
16.4%CHF 380.00CHF 162.95CHF 239.9622
Jan ’24CHF 222.68
CHF 280.81
+26.1%
20.0%CHF 420.00CHF 162.95CHF 273.6021
Dec ’23CHF 246.40
CHF 281.00
+14.0%
20.0%CHF 420.00CHF 162.95CHF 236.1521
Nov ’23CHF 228.74
CHF 280.02
+22.4%
20.2%CHF 420.00CHF 162.95CHF 215.2021

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies